Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

Aurore Perrot,Valérie Lauwers-Cances,Elodie Tournay,Cyrille Hulin,Marie-Lorraine Chretien,Bruno Royer,Mamoun Dib,Olivier Decaux,Arnaud Jaccard,Karim Belhadj,Sabine Brechignac,Jean Fontan,Laurent Voillat,Hélène Demarquette,Philippe Collet,Philippe Rodon,Claudine Sohn,François Lifermann,Frédérique Orsini-Piocelle,Valentine Richez,Mohamad Mohty,Margaret Macro,Stephane Minvielle,Philippe Moreau,Xavier Leleu,Thierry Facon,M. Attal,Hervé Avet-Loiseau,Jill Corre

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma

2019

PURPOSEThe wide heterogeneity in multiple myeloma (MM) outcome is driven mainly by cytogenetic abnormalities. The current definition of high-risk profile is restrictive and oversimplified. To adapt...

Keywords:

Pathology
Oncology
Multiple myeloma
Internal medicine
Medicine
MEDLINE

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations